My recent interview with Whitney Webb on Unlimited Hangout

https://www.forbes.com/sites/alexknapp/2020/03/13/coronavirus-drug-update-the-latest-info-on-pharmaceutical-treatments-and-vaccines/#49181a7e21db Expect to see ASO3 or related adjuvant from GSK in experimental Coronavirus vaccines: GSK has previously developed a pandemic vaccine adjuvant platform, a system that helps to improve vaccines by strengthening the immune response in patients who receive it. In February, the company announced it was partnering with the Coalition for Epidemic Preparedness Innovations to use that platform…

What could be worse than giving potentially lethal doses of hydroxychloroquine to Hospitalized Covid-19 patients? The REMAP-Covid study is using the same HCQ dose as the Recovery trial for 6 days.  But it is even worse for the following reasons: You have to be close to death, either on a ventilator or in shock, on…

A letter published in the Journal of Environmental and Occupational Medicine, April 2004 described two lab workers using standard procedures to grow and handle anthrax at USAMRIID. Despite this, medium leaked from a flask and spores were recovered from the nares of one of the workers. The potential for inhalation anthrax was considered serious, and…

In that same panel on vaccines, another panelist alleged that vaccines are a low-margin product and a low profit industry.  It was said that many companies left the market. That was true once.  This is now.  There are few companies due to tremendous market consolidation in pharmaceutical companies overall. Prices of vaccines have gone crazy….

More material has been released on the anthrax letters case by the Army: https://mrmc.amedd.army.mil/index.cfm?pageid=foia_reading_room.overview Contact for questions (the person overseeing the production) John P Mr CIV USA MEDCOM HQ Peterson   Also see:  http://www.newanthraxandalqaeda.com http://www.blurb.com/books/1443811 From: [redacted] To: [redacted] Sent: Wednesday, December 12, 2007 12:30 PM To: Subject: Question about MRIID (UNCLASSIFIED) Classification: UNCLASSIFIED Caveats:…